Clinical trials for Cancer in United States

Video Inspired Discussions About Ethical Outcomes in Pediatrics

Study ID: NCT06786104

Sponsor

Massachusetts General Hospital

IDENTIFY Study: Natural History of Maternal Neoplasia

Study ID: NCT04049604

Sponsor

National Human Genome Research Institute (NHGRI)

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Study ID: NCT06528301

Sponsor

Union biopharma

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

Study ID: NCT06047301

Sponsor

Laurie McLouth

Rural Colon Cancer Screening Toolkit Intervention

Study ID: NCT04651504

Sponsor

Washington University School of Medicine

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Study ID: NCT05661201

Sponsor

Georgetown University

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Study ID: NCT06220201

Sponsor

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

Study ID: NCT04594772

Sponsor

University of Cincinnati

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Study ID: NCT05203172

Sponsor

Pfizer

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Study ID: NCT05094804

Sponsor

OncoResponse, Inc.